Matthew H. Kulke, MD
Zoltan Kohn Professor of Medicine, Department of Medicine, Chobanian & Avedisian School of Medicine; Chief, Section of Hematology and Medical Oncology, Boston Medical Center; Co-Director, BU-BMC Cancer Center; Co-Director, Clinical Cancer Center, BMC
- Title Zoltan Kohn Professor of Medicine, Department of Medicine, Chobanian & Avedisian School of Medicine; Chief, Section of Hematology and Medical Oncology, Boston Medical Center; Co-Director, BU-BMC Cancer Center; Co-Director, Clinical Cancer Center, BMC
- Education University of California, San Francisco School of Medicine; Harvard Medical School, MS in medical science; Brigham and Women’s Hospital, Internal Medicine, residency; Dana-Farber Cancer Institute, medical oncology fellowship
Dr. Kulke is a leader in the research and treatment of neuroendocrine tumors, he has received numerous awards for his accomplishments as a clinical and translational investigator and as a provider of compassionate care to patients. He has published over 200 peer-reviewed articles and led national and international clinical trials to identify new therapeutic and diagnostic approaches to neuroendocrine tumors. He has served as Chair of the Neuroendocrine Tumor Task Force for the National Cancer Institute, Chair of the North American Neuroendocrine Tumor Society, and Chair of the National Comprehensive Cancer Network’s neuroendocrine tumor guideline committee. Dr. Kulke is thrilled to join the Shipley Center team in finding new discoveries and developing new therapies for prostate cancer.
Learn more about Dr. Kulke.